Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 8;16:1767–1778. doi: 10.2147/DDDT.S366531

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 Zhou et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Representative images of tumor tissues after anti-CD31 staining (bar=25 μm). Mice were iv injected with free MGF, MGF-SLNs and Tf-MGF-SLNs at a MGF dose of 10 mg/kg via the tail vein on days 6, 9, and 12 after tumor implantation. Controls included mice that were injected with blank SLNs. (A) Blank SLNs; (B) free MGF; (C) MGF-SLNs; (D) Tf-MGF-SLNs.